Experience the power of 360° ultrasound.
Paradise® Ultrasound Renal Denervation System
Deliver lasting outcomes.
Renal Denervation is now a proven adjunct treatment for managing high blood pressure.
Blood pressure reductions observed across clinical studies at multiple timepoints.
3 out of 3
The only RDN technology with 3 out of 3 successful U.S. randomized controlled trials, and only true resistant hypertension study found to reduce blood pressure.1-3, *
-17.3 mmHg
RADIANCE-HTN TRIO
Office SBP reduction at 36 months (Resistant hypertension with baseline
≥ 150 mmHg, N=30)4
-19.6 mmHg
GPS Registry (EMEA)
Office SBP reduction at 6 months in combination with medication therapy (Uncontrolled hypertension ≥ 140 mmHg, N=92)5
1. Azizi et al. Lancet. 2018 Jun 9;391(10137):2335-2345.; 2. Azizi et al. JAMA. 2023 Feb 28;329(8):651-661. 3. Azizi et al. Lancet. 2021 Jun 26;397(10293):2476-2486.1. 4.Bloch et al. Hypertens Res. 2024. (In patient population with baseline office SBP ≥ 150 mmHG) 5.Fengler K. TCT-580. Presented at TCT 2025; October 2025
* Baseline measurement occurred following 4-week standardization on a 3-drug single-pill.
Potential procedure-rated AEs including pain, vascular access site complications, and vasospasm are most common. Individual results may vary. See Important Safety Information.
The Paradise uRDN System
We’re changing the game in hypertension management.
